Termination of Development. At any time, and upon notice to PDLP, CVBT may elect to terminate the Development process due to insufficient progress or outright inability to make progress toward a commercially marketable wound healing drug.
Appears in 1 contract
Samples: Development Agreement (CardioVascular BioTherapeutics, Inc.)
Termination of Development. At any time, and upon notice to PDLP, CVBT may elect to terminate the Development process due to insufficient progress progress, overwhelming competition or outright inability to make progress toward a commercially marketable wound healing drug.
Appears in 1 contract
Samples: Technology License Agreement (CardioVascular BioTherapeutics, Inc.)
Termination of Development. At any time, and upon notice to PDLPCDCP, CVBT may elect to terminate the Development process due to insufficient progress or outright inability to make progress toward a commercially marketable wound healing drug.
Appears in 1 contract
Samples: Development Agreement (CardioVascular BioTherapeutics, Inc.)
Termination of Development. At any time, and upon notice to PDLPCDCP, CVBT may elect to terminate the Development process due to insufficient progress progress, overwhelming competition or outright inability to make progress toward a commercially marketable wound healing drug.
Appears in 1 contract
Samples: Technology License Agreement (CardioVascular BioTherapeutics, Inc.)